135 related articles for article (PubMed ID: 21389059)
21. Estrogen-induced retinoic acid receptor alpha 1 gene expression: role of estrogen receptor-Sp1 complex.
Sun G; Porter W; Safe S
Mol Endocrinol; 1998 Jun; 12(6):882-90. PubMed ID: 9626663
[TBL] [Abstract][Full Text] [Related]
22. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
[TBL] [Abstract][Full Text] [Related]
23. Alternatively spliced tissue factor synergizes with the estrogen receptor pathway in promoting breast cancer progression.
Kocatürk B; Tieken C; Vreeken D; Ünlü B; Engels CC; de Kruijf EM; Kuppen PJ; Reitsma PH; Bogdanov VY; Versteeg HH
J Thromb Haemost; 2015 Sep; 13(9):1683-93. PubMed ID: 26179105
[TBL] [Abstract][Full Text] [Related]
24. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
Treeck O; Lattrich C; Springwald A; Ortmann O
Breast Cancer Res Treat; 2010 Apr; 120(3):557-65. PubMed ID: 19434490
[TBL] [Abstract][Full Text] [Related]
25. Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.
Han Y; Yang L; Suarez-Saiz F; San-Marina S; Cui J; Minden MD
Mol Cancer Res; 2008 Aug; 6(8):1347-55. PubMed ID: 18708366
[TBL] [Abstract][Full Text] [Related]
26. Regulation of estrogen receptor expression in breast cancer.
Martin MB; Saceda M; Lindsey RK
Adv Exp Med Biol; 1993; 330():143-53. PubMed ID: 8368130
[TBL] [Abstract][Full Text] [Related]
27. Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer.
Jia X; Hong Q; Lei L; Li D; Li J; Mo M; Wang Y; Shao Z; Shen Z; Cheng J; Liu G
Oncotarget; 2015 Apr; 6(11):8648-62. PubMed ID: 25929338
[TBL] [Abstract][Full Text] [Related]
28. EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity.
Lu M; Miller KD; Gokmen-Polar Y; Jeng MH; Kinch MS
Cancer Res; 2003 Jun; 63(12):3425-9. PubMed ID: 12810680
[TBL] [Abstract][Full Text] [Related]
29. Estrogen regulates JNK1 genomic localization to control gene expression and cell growth in breast cancer cells.
Sun M; Isaacs GD; Hah N; Heldring N; Fogarty EA; Kraus WL
Mol Endocrinol; 2012 May; 26(5):736-47. PubMed ID: 22446103
[TBL] [Abstract][Full Text] [Related]
30. Adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer.
Wang ZX; Bian HB; Yang JS; De W; Ji XH
Cancer Biol Ther; 2009 Aug; 8(15):1480-8. PubMed ID: 19571664
[TBL] [Abstract][Full Text] [Related]
31. Differential toxicological endpoints of di(2-ethylhexyl) phthalate (DEHP) exposure in MCF-7 and MDA-MB-231 cell lines: possible estrogen receptor alpha (ERalpha) independent modulations.
Tanay Das M; Kumar M; Thakur IS
Indian J Exp Biol; 2014 Nov; 52(11):1052-61. PubMed ID: 25434100
[TBL] [Abstract][Full Text] [Related]
32. Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines.
Rizza P; Barone I; Zito D; Giordano F; Lanzino M; De Amicis F; Mauro L; Sisci D; Catalano S; Dahlman Wright K; Gustafsson JA; Andò S
Breast Cancer Res; 2014 Feb; 16(1):R21. PubMed ID: 24552459
[TBL] [Abstract][Full Text] [Related]
33. Estrogen and resveratrol regulate Rac and Cdc42 signaling to the actin cytoskeleton of metastatic breast cancer cells.
Azios NG; Krishnamoorthy L; Harris M; Cubano LA; Cammer M; Dharmawardhane SF
Neoplasia; 2007 Feb; 9(2):147-58. PubMed ID: 17356711
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
35. MEL-18 loss mediates estrogen receptor-α downregulation and hormone independence.
Lee JY; Won HY; Park JH; Kim HY; Choi HJ; Shin DH; Kang JH; Woo JK; Oh SH; Son T; Choi JW; Kim S; Kim HY; Yi K; Jang KS; Oh YH; Kong G
J Clin Invest; 2015 May; 125(5):1801-14. PubMed ID: 25822021
[TBL] [Abstract][Full Text] [Related]
36. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
Bradley LM; Gierthy JF; Pentecost BT
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
[TBL] [Abstract][Full Text] [Related]
37. Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells.
Zavodovskaya M; Campbell MJ; Maddux BA; Shiry L; Allan G; Hodges L; Kushner P; Kerner JA; Youngren JF; Goldfine ID
J Cell Biochem; 2008 Feb; 103(2):624-35. PubMed ID: 17562544
[TBL] [Abstract][Full Text] [Related]
38. RAR agonists stimulate SOX9 gene expression in breast cancer cell lines: evidence for a role in retinoid-mediated growth inhibition.
Afonja O; Raaka BM; Huang A; Das S; Zhao X; Helmer E; Juste D; Samuels HH
Oncogene; 2002 Nov; 21(51):7850-60. PubMed ID: 12420222
[TBL] [Abstract][Full Text] [Related]
39. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
[TBL] [Abstract][Full Text] [Related]
40. Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer.
Datta D; Flaxenburg JA; Laxmanan S; Geehan C; Grimm M; Waaga-Gasser AM; Briscoe DM; Pal S
Cancer Res; 2006 Oct; 66(19):9509-18. PubMed ID: 17018607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
